The UKMS Pharmacy Group was established in the Summer of 2021, led by Andrea Preston, with the inaugural meeting of the core steering group taking place in January 2022.

The aim of the Group is to promote excellence in the pharmaceutical care of patients with myeloma.

The group supports pharmacy education delivering an annual pharmacy education day aiming to address current topics important to the wider pharmacy community.

We develop guidelines and encourage cancer pharmacists to undertake high quality, audit and research (aligned with UKMS and UK MRA workplans). The group supports standardisation of clinical pharmacy practice across the UK.

We have established a growing network of pharmacists with a specialist interest in myeloma across the UK. This provides increased opportunity for peer support and encourage sharing of good clinical practice.